| Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus–coinfected individuals from 2001 to 2014: a multicohort study LI Gjærde, L Shepherd, E Jablonowska, A Lazzarin, M Rougemont, ... Clinical infectious diseases 63 (6), 821-829, 2016 | 65 | 2016 |
| Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: relevance for screening strategies G Wandeler, E Mauron, A Atkinson, JF Dufour, D Kraus, P Reiss, L Peters, ... Journal of hepatology 71 (2), 274-280, 2019 | 36 | 2019 |
| Epidemiology of bloodstream infections after myeloablative and non‐myeloablative allogeneic hematopoietic stem cell transplantation: a single‐center cohort study LI Gjaerde, C Moser, H Sengeløv Transplant Infectious Disease 19 (5), e12730, 2017 | 30 | 2017 |
| Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease LK Gjærde, M Schmidt, H Sengeløv Bone Marrow Transplantation 53 (8), 1061-1064, 2018 | 11 | 2018 |
| Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: a comparison of pre‐and post‐transplantation cytokine responses in stimulated whole … LK Gjærde, PT Brooks, NS Andersen, LS Friis, B Kornblit, SL Petersen, ... Scandinavian Journal of Immunology 94 (1), e13042, 2021 | 9 | 2021 |
| Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients R Svanberg, C MacPherson, A Zucco, R Agius, T Faitova, MA Andersen, ... Communications medicine 2 (1), 114, 2022 | 8 | 2022 |
| Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation LK Gjærde, NS Andersen, LS Friis, B Kornblit, SL Petersen, I Schjødt, ... Bone Marrow Transplantation 55 (7), 1457-1459, 2020 | 5 | 2020 |
| Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training C Horgan, Y Serroukh, LK Gjærde, N Gagelmann The Lancet Haematology 9 (5), e323-e324, 2022 | 4 | 2022 |
| Pre-transplantation plasma vitamin D levels and acute graft-versus-host disease after myeloablative hematopoietic cell transplantation in adults LK Gjaerde, SR Ostrowski, NS Andersen, LS Friis, B Kornblit, SL Petersen, ... Transplant Immunology 68, 101437, 2021 | 4 | 2021 |
| Vitamin E and acute graft‐versus‐host disease after myeloablative allogeneic hematopoietic cell transplantation LK Gjærde, SR Ostrowski, L Minculescu, NS Andersen, LS Friis, ... European Journal of Haematology 106 (3), 417-424, 2021 | 4 | 2021 |
| Development of video tutorials to help parents manage children with acute illnesses using a modified Delphi method L Borch‐Johnsen, L Andrés‐Jensen, F Folke, MM Espersen, SL Amstrup, ... Acta Paediatrica 112 (7), 1574-1585, 2023 | 3 | 2023 |
| Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant … LK Gjærde, C Eeltink, J Stringer, J Mooyaart, P Bosman, M Kenyon, ... Bone marrow transplantation 58 (2), 195-202, 2023 | 3 | 2023 |
| Pretransplantation plasma ST2 level as a prognostic biomarker of 1-Year nonrelapse mortality in allogeneic hematopoietic cell transplantation LK Gjærde, SR Ostrowski, F Schierbeck, NS Andersen, LS Friis, B Kornblit, ... Transplantation and cellular therapy 29 (2), 97. e1-97. e6, 2023 | 3 | 2023 |
| Hypomethylating agent-based therapies in older adults with acute myeloid leukemia–A joint review by the Young International Society of Geriatric Oncology and European Society … NR Neuendorff, N Gagelmann, S Singhal, S Meckstroth, V Thibaud, ... Journal of Geriatric Oncology 14 (3), 101406, 2023 | 2 | 2023 |
| Fitting parametric cure models in R using the packages cuRe and rstpm2 RK Jensen, M Clements, LK Gjærde, LH Jakobsen Computer Methods and Programs in Biomedicine 226, 107125, 2022 | 2 | 2022 |
| Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation LK Gjærde, ALT Sørensen, JH von Stemann, A Fischer-Nielsen, ... Transplantation and cellular therapy 27 (10), 866. e1-866. e9, 2021 | 2 | 2021 |
| Triple-drug graft-versus-host disease prophylaxis after HLA-matched unrelated donor nonmyeloablative allogenic hematopoietic stem cell transplantation A Wegener, NS Andersen, LS Friis, SL Petersen, I Schjødt, B Kornblit, ... Transplantation and cellular therapy 29 (9), 575. e1-575. e6, 2023 | 1 | 2023 |
| Ocular chronic graft-versus-Host disease and its relation to other organ manifestations and outcomes after allogeneic hematopoietic cell transplantation H Jeppesen, LK Gjærde, J Lindegaard, HO Julian, S Heegaard, ... Transplantation and cellular therapy 28 (12), 833. e1-833. e7, 2022 | 1 | 2022 |
| Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation LK Gjærde, SR Ostrowski, NR Jørgensen, F Schierbeck, NS Andersen, ... Transplant Immunology 74, 101650, 2022 | 1 | 2022 |
| Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study LK Gjærde, CU Rank, MK Andersen, LH Jakobsen, H Sengeløv, G Olesen, ... Leukemia & Lymphoma 63 (2), 416-425, 2022 | 1 | 2022 |
